Skip to main content
Log in

Assessment of “Ca2+-antagonist” effects of drugs in K+-depolarized smooth muscle

Differentiation of antagonist subgroups

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

  1. 1.

    Taenia preparations from the guinea-pig caecum yielded reproducible concentration-response curves to Ca2+ (EC 50 134±8 μmol/l) when maintained in depolarizing Tyrode solution containing K+ (40 mmol/l). Drugs which are claimed to be “Ca2--antagonists” displaced the curves to the right without depression of the maximum response. In this test nifedipine, verapamil, diltiazem, pimozide, cinnarizine, flunarizine and fendiline appeared qualitatively similar but had different potencies.

  2. 2.

    The antagonist effects of nifedipine, verapamil and diltiazem were readily reversed by washout of the drugs from the bathing fluid, but the effects of the other drugs were not.

  3. 3.

    Cinnarizine, flunarizine, pimozide and fendiline were only weakly active as relaxants of Ca2+ (100 μmol/l)-induced contractions, when compared with their antagonist activity when applied initially in Ca2+-free media. As the presence of Ca2+ (100 μmol/l) in the K+-Tryrode reduced the antagonist effects of cinnarizine and pimozide, but not that of verapamil and diltiazem, the weak activity of some of the antagonists as relaxants of Ca2+-induced contractions can be attributed to a protective effect of Ca2+ during the incubation period with the antagonist.

  4. 4.

    The problems associated with the assessment of the potency of drugs as “Ca2+-antagonists” are discussed and it is proposed that three subgroups of drugs may exist within the overall classification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14:48–58

    Google Scholar 

  • Bossert VF, Horstmann H, Meyer H, Vater W (1979) Einfluß der Esterfunktion auf die vasodilatierenden Eigenschaften von 1,4-dihydro-2,6-dimethyl-4-nitrophenyl-pyridin-3,5-dicarbonsäureestern. Arzneim Forsch 29:226–229

    Google Scholar 

  • Bayer R, Ehara T (1977) Comparative studies on calcium antagonists. Prog Pharmacol 2:31–37

    Google Scholar 

  • Brading AF, Sneddon P (1980) Evidence for multiple sources of calcium for activation of the contractile mechanism of guinea-pig taenia coli on stimulation with carbachol. Br J Pharmacol 70:229–240

    Google Scholar 

  • Church J, Zsotér TT (1980) Calcium antagonist drugs. Mechanism of action. Can J Physiol Pharmacol 58:254–264

    Google Scholar 

  • Durbin RP, Jenkinson DH (1961) The calcium dependence of tension development in depolarized smooth muscle. J Physiol Lond 157:90–96

    Google Scholar 

  • Ferrari M (1970) Interactions between calcium and some myolytic agents on depolarized vascular smooth muscle. J Pharm Pharmacol 22:71–72

    Google Scholar 

  • Ferrari M, Carpenedo F (1968) On the mechanism of action of some myolytic agents on depolarized guinea, pig taenia coli. Arch Int Pharmacodyn 174:223–232

    Google Scholar 

  • Fleckenstein A (1977) Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol Toxicol 17:149–166

    Google Scholar 

  • Fleckenstein A, Fleckenstein-Grün G, Byon YK (1977) Cardiovascular effects of the Ca2+-antagonistic coronary drug Fendiline (Sensit). Arzneim Forsch 27:562–571

    Google Scholar 

  • Frank JS, Langer GA, Nudd LM, Seraynoudarian K (1977) The myocardial cell surface, its histochemistry, and the effects of sialic acid and calcium removal on its structure and cellular ionic exchange. Circ Res 41:702–714

    Google Scholar 

  • Godfraind T, Kaba A (1969) Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle. Br J Pharmacol 36:549–560

    Google Scholar 

  • Golenhofen K, Wagner B, Weston AH (1977) Calcium systems of smooth muscle and their selective inhibition. In: Casteels R, Godfraind T, Rüegg JC (eds) Excitation-contraction coupling in smooth muscle. Elsevier, Amsterdam, pp 131–136

    Google Scholar 

  • Haeusler G (1972) Differential effects of verapamil on excitation-contraction coupling in smooth muscle and on excitation-secretion coupling in adrenergic nerve terminals. J Pharmacol Exp Ther 180:672–682

    Google Scholar 

  • Hashimoto K, Nakagawa Y, Nabata H, Imai S (1978) In vitro analysis of Ca-antagonistic effects of prenylamine as mechanisms for its cardiac actions. Arch Int Pharmacodyn 231:212–221

    Google Scholar 

  • Henry PD (1980) Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol 46:1047–1058

    Google Scholar 

  • Hille B (1977) Local anaesthetics: hydrophilic and hydrophobic pathways for the drug receptor reaction. J Gen Physiol 69:497–515

    Google Scholar 

  • Imai S (1979) Antiangial drugs-revival of interest in vasodilators. Trends Pharmacol Sci 1:87–89

    Google Scholar 

  • Jetley M, Weston AH (1980) Some effects of sodium nitroprusside, methoxyverapamil (D600) and nifedipine on rat portal vein. Br J Pharmacol 68:311–319

    Google Scholar 

  • Levin RM, Weiss B (1979) Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther 208:454–459

    Google Scholar 

  • Loev B, Goodman MM, Snader KM, Tedeschi R, Macko E (1974) “Hantzsch-type” dihydropyridine hypotensive agents. J Med Chem 17:956–965

    Google Scholar 

  • Morel N, Godfraind T (1978) Action of calcium antagonists on microsomal calcium activated ATPase of rat aorta. Arch Int Pharmacodyn 236:315–316

    Google Scholar 

  • Nabata H (1977) Effects of calcium-antagonistic coronary vasodilators on myocardial contractility and membrane potentials. Jpn J Pharmacol 27:239–249

    Google Scholar 

  • Nakayama K, Kasuya Y (1980) Selective abolition of Ca-dependent responses of smooth and cardiac muscles by flunarizine. Jpn J Pharmacol 30:731–742

    Google Scholar 

  • Opie LH (1980) Calcium antagonists. Lancet I:806–810

    Google Scholar 

  • Quintana A (1978) Effects of pimozide on the response of smooth muscle to non-dopamine agonists and calcium. Eur J Pharmacol 53:113–116

    Google Scholar 

  • Racker E (1980) Fluxes of Ca2+ and concepts. Fed Proc 39:2422–2426

    Google Scholar 

  • Rahwan RG, Piascik MF, Witiak DT (1979) The role of calcium antagonism in the therapeutic action of drugs. Can J Physiol Pharmacol 57:443–460

    Google Scholar 

  • Sanner JH, Prusa CM (1980) Inhibition by verapamil of contractions produced by calcium on depolarized rabbit aortic strips. Life Sci 27:2565–2570

    Google Scholar 

  • Spedding M (1981) Marked differences in the effects of “Ca2+-antagonists” on CaCl2-induced contractions in K+-depolarized smooth muscle Br J Pharmacol 72: 144P

  • Spedding M, Weetman DF (1978) The mechanism of the relaxant effect of 2-2′-pyridylisatogen on the isolated taenia of the guinea-pig caecum. Br J Pharmacol 63:659–664

    Google Scholar 

  • Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol Chemother 11:379–393

    Google Scholar 

  • Thorens S, Haeusler G (1979) Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur J Pharmacol 54:79–91

    Google Scholar 

  • Tomiyama A, Takayanagi I, Takagi K (1973) Relaxation of intestinal smooth muscle and calcium movements. J Pharm Pharmacol 25:65–68

    Google Scholar 

  • Van Breemen C (1977) Calcium requirement for activation of intact aortic smooth muscle. J Physiol Lond 272:317–329

    Google Scholar 

  • Van Nueten JM, Vanhoutte PM (1980) Improvement of tissue perfusion with inhibitors of calcium ion influx. Biochem Pharmacol 29:479–481

    Google Scholar 

  • Van Nueten JM, Van Beck J, Janssen PAJ (1978) Effect of flunarizine on calcium-induced responses of peripheral vascular smooth muscle. Arch Int Pharmacodyn 232:42–52

    Google Scholar 

  • Van Rossum JM (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299–330

    Google Scholar 

  • Weston AH (1978) The effect of noradrenaline on electrical activity and calcium fluxes in rat portal vein. In: Szabadi E, Bradshaw CM, Bevan P (eds) Recent advances in the pharmacology of adrenoceptors. Elsevier, Amsterdam, pp 15–22

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spedding, M. Assessment of “Ca2+-antagonist” effects of drugs in K+-depolarized smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol. 318, 234–240 (1982). https://doi.org/10.1007/BF00500485

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00500485

Key words

Navigation